HZNP Stock News 12.88 05/18/2014 18:20:03 Horizon Pharma Inc

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Horizon Pharma Inc (HZNP) 12.88 $HZNP

Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co.
PR Newswire - Fri May 16, 6:20AM CDT
Today, Analysts Review released its analysts' notes regarding Zoetis Inc. (NYSE: ZTS), Horizon Pharma, Inc. (NASDAQ: HZNP), Akorn, Inc. (NASDAQ: AKRX), Furiex Pharmaceuticals, Inc. (NASDAQ: FURX) and Medicines Co. (NASDAQ: MDCO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/2536-100free.

Horizon guides '14 sales up
at Investor's Business Daily - Fri May 09, 6:25PM CDT
The specialty drugmaker swung to a Q1 profit of 13 cents a share from a year-earlier loss of 36 cents. Analysts expected Horizon Pharma (HZNP) to make 1 cent. Sales soared to $51.9 mil up from $8.7 mil, topping views, on sales of arthritis painkiller...

Horizon Pharma Q1 Beats Street; Guidance Mixed
at Investor's Business Daily - Fri May 09, 10:12AM CDT
Specialty drugmaker Horizon Pharma (HZNP) beat analysts' Q1 estimates and raised its sales guidance Friday morning, briefly rallying the stock on the stock market today. Horizon reported its first quarterly profit, excluding one-time items, making 13...

Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance
Marketwire - Fri May 09, 5:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today provided an update on the Company's business and announced financial results for the first quarter ended March 31, 2014.

Horizon Pharma (HZNP) Sees Hammer Chart Pattern: Time to Buy? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 01, 6:18AM CDT
Horizon Pharma (HZNP) Sees Hammer Chart Pattern: Time to Buy?

Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co
PR Newswire - Wed Apr 30, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Mylan, Inc. (NASDAQ: MYL), Zoetis Inc. (NYSE: ZTS), Hospira Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP) and The Medicines Co. (NASDAQ: MDCO). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1816-100free.

Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 9, 2014
Marketwire - Fri Apr 25, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) announced today that its first quarter 2014 financial results will be released on Friday, May 9, 2014. Following the announcement, Horizon's management will host a live conference call and webcast at 8:00 am Eastern Time to review the Company's financial and operating results and provide a general business update.

Horizon Pharma awards inducement grants in accordance with NASDAQ Listing Rule 5635(c)(4)
M2 - Thu Apr 24, 5:03AM CDT
Pharmaceutical company Horizon Pharma (NASDAQ:HZNP) on Wednesday granted stock options to ten new non-executive employees to purchase up to 76,500 shares of its common stock.

Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Marketwire - Wed Apr 23, 3:35PM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that on April 23, 2014 the Compensation Committee of its Board of Directors granted inducement awards to 10 new employees.

Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games
PR Newswire - Wed Apr 23, 10:34AM CDT
On Tuesday, April 22, 2014, the NASDAQ Composite ended at 4,161.46, up 0.97%, the Dow Jones Industrial Average finished the session 0.40% higher at 16,514.37, and the S&P 500 closed at 1,879.55, up 0.41%. The gains were broad based as eight out of ten sectors finished on a higher note. A number of stocks saw large movements, including Centene Corp. (NYSE: CNC), Prana Biotechnology Ltd (NASDAQ: PRAN), Horizon Pharma Inc. (NASDAQ: HZNP) and Scientific Games Corp. (NASDAQ: SGMS). Free technical research on CNC, PRAN, HZNP and SGMS can be downloaded upon signing up at:

Is A Short Squeeze Ahead for Horizon Pharma (HZNP)? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Apr 21, 7:41AM CDT
Is A Short Squeeze Ahead for Horizon Pharma (HZNP)?

Horizon Pharma elects H Thomas Watkins to board
M2 - Fri Apr 18, 6:53AM CDT
Pharmaceutical company Horizon Pharma (NasdaqGS:HZNP) revealed on Thursday the addition of H Thomas Watkins to its board of directors.

Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board of Directors
Marketwire - Thu Apr 17, 6:31AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced the appointment of H. Thomas Watkins, former director, president and chief executive officer of Human Genome Sciences, to its board of directors. Additionally, Jean-Francois Formela, M.D. has resigned from the Horizon board of directors.

Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd.
Marketwire - Wed Apr 16, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that it has received notice of the early termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act, in connection with its proposed acquisition of Vidara Therapeutics International Ltd. ("Vidara" . The waiting period was scheduled to expire on May 1, 2014. Completion of the transaction remains subject to approval by Horizon's stockholders and other customary closing conditions.

Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin
PR Newswire - Fri Apr 11, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Actavis plc (NYSE: ACT), The Medicines Company (NASDAQ: MDCO), Hospira, Inc. (NYSE: HSP), Horizon Pharma, Inc. (NASDAQ: HZNP), and Galectin Therapeutics Inc. (NASDAQ: GALT). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register

Horizon Pharma announces Notice of Allowance for US Patent Application for RAYOS for treating a broad range of diseases
M2 - Fri Apr 11, 4:56AM CDT
Specialist pharmaceutical company Horizon Pharma (NASDAQ:HZNP) revealed on Thursday the receipt of Notice of Allowance for US Patent Application 13/713,528 entitled "Delayed-Release Tablet with Defined Core Geometry" that covers its US approved product RAYOS.

Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Apr 10, 7:33AM CDT
Horizon Pharma looks well positioned for a solid gain, but has been overlooked by investors lately. This Generic Drugs stock has actually seen estimates rise over the past month for the current fiscal year. This year’s expected earnings growth over the prior year is 147.1%, which should ultimately translate into price appreciation.

Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets
Marketwire - Thu Apr 10, 6:30AM CDT
Horizon Pharma, Inc. (NASDAQ: HZNP) today announced that Skyepharma has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) for U.S. Patent Application 13/713,528 entitled "Delayed-Release Tablet with Defined Core Geometry" that covers the Company's U.S. approved product RAYOS(R).

Nasdaq stocks posting largest percentage decreases
AP - Thu Apr 03, 12:47PM CDT
NEW YORK (AP) — A look at the 10 biggest percentage decliners on Nasdaq at 1 p.m.:

Technical Data on Top Gainers -- Research on JinkoSolar, Horizon Pharma, YY Inc., and Questcor Pharma
PR Newswire - Wed Apr 02, 8:59AM CDT
On Tuesday, April 01, 2014, the US markets saw a positive sentiment, with the NASDAQ Composite closing at 4,268.04, up 1.64%, the Dow Jones Industrial Average ending the session at 16,532.61, up 0.46% and the S&P 500 edging 0.70% higher to finish the trading session at 1,885.52. The session saw a positive impact from Consumer Discretionary, Information Technology and Industrials sectors along with a drag from Utilities, and Consumer Staples sectors. A number of stocks saw large movements, including JinkoSolar Holding Co. Ltd (NYSE: JKS), Horizon Pharma Inc. (NASDAQ: HZNP), YY Inc. (NASDAQ: YY) and Questcor Pharmaceuticals Inc. (NASDAQ: QCOR). Free technical research on JKS, HZNP, YY and QCOR can be downloaded upon signing up at:
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Veritran's Bold Move: Acquiring PrismaCampaigns Inc.

Updated Category News Views 58

Veritran's Strategic Leap Forward They're not messing around, folks. Veritran just made a power move by acquiring 100% of PrismaCampaigns Inc., and it’s more than just another day in the office. This marks a pivotal expansion of their American footprint, and they're zeroing in on our banks and credit unions with laser precision. Why This Matters for Financial...

Continue Reading
Daymond John's Four-Center Bet on Longevity Game

Updated Category News Views 42

A Shark's Dive into Longevity Here you go—Daymond John, the face of FUBU and a household name from Shark Tank, is not just talking about living longer; he's putting his wallet where his words are. John is jumping into the longevity game with both feet, joining Ultimate Longevity Center's (ULC) latest venture. We're talking about four new centers across California,...

Continue Reading
Gwen Stefani Kicks Off OCVIBE's New Concert Hall

Updated Category News Views 174

A Homecoming Steeped in Nostalgia Orange County’s about to do a serious throwback, folks! Gwen Stefani is set to headline the opening concert at OCVIBE's spanking new concert hall in Anaheim on March 17, 2027. Curious choice for their opener? Hardly. This gal's practically woven into the county’s tapestry—her roots run deep here, enough to make even the casual music...

Continue Reading
Tenax Class Action: Investors Alley Fight for Redress

Updated Category News Views 15

Tenax Therapeutics in Hot Water Over Drug Trial Results Amidst the ever-unpredictable tides of the pharmaceutical industry, here comes a doozy – Tenax Therapeutics, Inc. is neck-deep in a shareholder lawsuit. If you tossed some money at NASDAQ:TENX anytime between November 13, 2023, and August 7, 2026, you might be feeling the sting of regret, and rightly so. What Went...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 203

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Disney+ Teams Up with Tiff's: Blue Cookie Debut

Updated Category News Views 52

A Sweet Collaboration on the Horizon If somebody had told me that cookies could conjure up excitement equivalent to a TV show's new season, I'd have laughed. But here we are—Disney+ and Tiff's Treats are cooking up a storm with blue chocolate chip cookies to celebrate 'Percy Jackson and the Olympians' Season 3 premiere. The Cookie That Packs a Punch Forget ordinary...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 22

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Insight Into Midland TX Real Estate Sales Timing

Updated Category News Views 15

How Fast Do Homes Move in Midland? This ain't my first rodeo predicting the real estate rollercoaster in Texas. Midland's housing market is one nifty beast—homes can either sell like hotcakes or just sit gathering dust. You got HelloNation pulling in DeLaura Gammage, a pro who knows the terrain like the back of her hand, to spell out the why and how long it'll take to...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 282

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 113

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading

Top 5 Most Recently Viewed Articles

BIEL Crystal's Innovative Smartphone Glass Cover Revolutionizes Durability

Updated Category News Views 299

BIEL Crystal's Innovative Smartphone Glass Cover BIEL Crystal, a notable supplier for Apple and a leader in smart device components, has recently introduced its cutting-edge product, the "Witch Cloak." This ultra-hard coating smartphone glass cover represents a significant advancement in the technology used to protect smartphones from daily wear and tear, notably featured...

Continue Reading
Covenant Clearinghouse Triumphs in Legal Battle with Chicago Title

Updated Category News Views 780

Covenant Clearinghouse Triumphs in Legal Battle Covenant Clearinghouse recently achieved a significant legal victory against the Chicago Title Company, concluding a complex litigation case. The case, documented as Chicago Title Ins. Co. v. Covenant Clearinghouse, LLC, revolved around crucial property rights under the Illinois Transfer Fee Covenant Act. Legal Proceedings...

Continue Reading
TTEC CEO's Buyout Proposal: What It Means for Stakeholders

Updated Category News Views 137

TTEC's CEO Buyout Proposal: Evaluating the Future TTEC Holdings, Inc. (NASDAQ: TTEC), known for its AI-driven customer experience solutions, is currently assessing a buyout proposal presented by its CEO, Kenneth Tuchman. This significant move has prompted the company to engage the services of Rothschild & Co as its financial advisor, alongside legal support from Skadden,...

Continue Reading
Primech AI Unveils HYTRON LITE Bathroom Cleaning Solution

Updated Category News Views 167

Primech AI Launches Innovative HYTRON LITE at Industry Event Primech AI Pte. Ltd. (Nasdaq: PMEC) is making waves in the robotics industry with its latest innovative creation, the HYTRON LITE bathroom cleaning robot, introduced during a significant event focused on facilities management. This gathering, that united key players, took place at Temasek Polytechnic and was...

Continue Reading
The Growth Journey of Travelers Companies: A Five-Year Analysis

Updated Category News Views 255

Understanding Travelers Companies' Market Performance When evaluating the potential return on investment in stocks, it's essential to look at the historical performance of companies like Travelers Companies (NYSE: TRV). This prominent insurance provider has shown remarkable consistency and growth over the years, recently achieving a market capitalization of $63.96...

Continue Reading